Anticoagulant Reversal Drugs Market to Register a Stout Growth by End 2025
Bleeding complications is a common concern associated with the use of anticoagulation drugs. Anticoagulant reversal drugs act as antidote agents to neutralize the condition that involves bleeding complications; for example, an unplanned surgery, hemophilia, etc. Anticoagulation reversal drugs are also required to support the medical treatment for prevention and reduction of recurrent deep-vein venous thromboembolism (VTE). These drugs reduce the incidence of recurrent ischemic events in patients with coronary syndrome. Anticoagulant reversal drugs such as idarucizumab contain selective monoclonal antibodies...
View full press release